Orion Therapeutics, Inc. is a therapeutic and RNA therapeutics company enabled by a novel delivery platform. The company is headquartered in Knoxville, Tennessee.
Subscribe to see Orion Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Orion Therapeutics, Inc. is a biotechnology company headquartered in Knoxville, United States. It has raised at least $145,000 across the 2 funding rounds on record. Its most recent funding round, Grant, raised $85,000 in September 2024. Xcout tracks 12 named people at Orion Therapeutics, Inc., including Richard (Trey) Fisher (Co-Founder, CEO & President).
As of 16 November 2026. Source: Xcout Intel.
6 more named people on record for Orion Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $145,000 raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $85,000 | 2 named | |
| SEC Form D filing | $60,000 | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 2 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Orion Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Orion Biotechnology Canada Ltd. is a drug discovery and development company headquartered in Ottawa, Canada. Founded in 2017, the firm focuses on researching and developing innovative therapeutics targeting complex diseases. Its scientific pipeline utilizes proprietary drug design platforms to create novel targeted treatments.
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Orna Therapeutics Holdings, LLC is associated with Orna Therapeutics, a biotechnology company developing circular RNA (oRNA)-based medicines. Its platform is intended to support therapies for patients, including potential applications in cancer and other diseases.
DTx Pharma, Inc. is a privately held biotechnology company based in San Diego, California, that addresses the challenges associated with delivering RNA-based therapeutics.
Expansion Therapeutics, Inc. is a biotechnology company founded in Jupiter, Florida, that specializes in developing RNA-targeting therapies.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Orion Therapeutics, Inc.? Suggest a correction · Work at Orion Therapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.